A detailed history of Virginia Retirement Systems Et Al transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 22,100 shares of ADPT stock, worth $141,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,100
Previous 20,400 8.33%
Holding current value
$141,219
Previous $136,000 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$5.07 - $8.44 $8,619 - $14,348
1,700 Added 8.33%
22,100 $120,000
Q1 2023

Jul 11, 2023

BUY
$7.8 - $10.11 $159,120 - $206,244
20,400 New
20,400 $180,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.